{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:28:01Z","timestamp":1794713281390,"version":"4.9.1"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Lundbeck Foundation","award":["R359 to 2020 to 2620"],"award-info":[{"award-number":["R359 to 2020 to 2620"]}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"crossref","award":["NNF20OC0065520"],"award-info":[{"award-number":["NNF20OC0065520"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["PR9"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Neuropathic pain is a challenging chronic pain condition. Limited knowledge exists regarding the relative effectiveness of pharmacological treatments, and differences in trial design and impact of the placebo response preclude indirect comparisons of efficacy between drug classes. The purpose of this systematic review and meta-analysis of head-to-head trials was to compare the efficacy and tolerability of drugs recommended for neuropathic pain. We conducted a systematic review and meta-analysis of direct-comparison double-blind randomized trials. Primary outcomes were mean change in pain intensity and number of responders with a 50% reduction in pain intensity. Secondary outcomes encompassed quality of life, sleep, emotional functioning, and number of dropouts because of adverse events. We included 30 trials (4087 patients), comprising 16 crossover and 14 parallel-group design studies. All studies were conducted in adults, and the majority were investigator-initiated trials. We found moderate-quality evidence for equivalence (no clinically relevant difference) between tricyclic antidepressants (TCA) and gabapentin\/pregabalin with a combined mean difference in pain score of 0.10 (95% CI \u22120.13 to 0.32). We could not document differences between TCA and serotonin\u2013noradrenaline reuptake inhibitors (SNRI), between SNRI and gabapentin\/pregabalin, or between opioids and TCA (low quality of evidence). We found more dropouts because of adverse events with SNRI and opioids compared with TCA (low quality of evidence). We did not identify any studies that included topical treatments. This systematic review of direct-comparison studies found evidence for equivalence between TCA and gabapentin\/pregabalin and fewer dropouts with TCA than SNRI and opioids.<\/jats:p>","DOI":"10.1097\/pr9.0000000000001138","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T17:02:01Z","timestamp":1708707721000},"page":"e1138","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["A systematic review and meta-analysis of randomized controlled head-to-head trials of recommended drugs for neuropathic pain"],"prefix":"10.1097","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2818-0734","authenticated-orcid":false,"given":"Ayda Asadizadeh","family":"Sadegh","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, Danish Pain Research Center, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina Lykkegaard","family":"Gehr","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Danish Pain Research Center, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna Brix","family":"Finnerup","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Danish Pain Research Center, Aarhus University, Aarhus, Denmark"},{"name":"Department of Neurology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4]]},"reference":[{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1464-5491.2009.02806.x","article-title":"Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial","volume":"26","author":"Bansal","year":"2009","journal-title":"Diabet Med"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jama.2012.208828","article-title":"Emergence of large treatment effects from small trials-reply","volume":"309","author":"Batterham","year":"2013","journal-title":"JAMA"},{"key":"R4-20240807","first-page":"Cd014682","article-title":"Antidepressants for pain management in adults with chronic pain: a network meta-analysis","volume":"5","author":"Birkinshaw","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jclinepi.2008.09.013","article-title":"The evidence provided by a single trial is less reliable than its statistical analysis suggests","volume":"62","author":"Borm","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2337\/dc12-0656","article-title":"Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life","volume":"35","author":"Boyle","year":"2012","journal-title":"Diabetes Care"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5414\/CPP44358","article-title":"Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial\u2014the GONIP Trial","volume":"44","author":"Chandra","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jama.2014.8166","article-title":"Association between analytic strategy and estimates of treatment outcomes in meta-analyses","volume":"312","author":"Dechartres","year":"2014","journal-title":"JAMA"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(97)02290-3","article-title":"Why \u201cunderpowered\u201d trials are not necessarily unethical","volume":"350","author":"Edwards","year":"1997","journal-title":"Lancet"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2147\/JPR.S170646","article-title":"Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin","volume":"11","author":"Enomoto","year":"2018","journal-title":"J Pain Res"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"e072415","DOI":"10.1136\/bmj-2022-072415","article-title":"Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews","volume":"380","author":"Ferreira","year":"2023","journal-title":"BMJ"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1097\/j.pain.0000000000001340","article-title":"Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacy","volume":"159","author":"Finnerup","year":"2018","journal-title":"PAIN"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","article-title":"Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial","volume":"374","author":"Gilron","year":"2009","journal-title":"Lancet"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/j.pain.0000000000000149","article-title":"Combination of morphine with nortriptyline for neuropathic pain","volume":"156","author":"Gilron","year":"2015","journal-title":"PAIN"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1371\/journal.pmed.0050004","article-title":"In the era of systematic reviews, does the size of an individual trial still matter","volume":"5","author":"Guyatt","year":"2008","journal-title":"PLoS Med"},{"key":"R19-20240807","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R21-20240807","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/j.pain.0000000000000143","article-title":"Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial","volume":"156","author":"Holbech","year":"2015","journal-title":"PAIN"},{"key":"R23-20240807","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/0962280212461098","article-title":"Obtaining evidence by a single well-powered trial or several modestly powered trials","volume":"25","author":"IntHout","year":"2016","journal-title":"Stat Methods Med Res"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpsychires.2015.12.016","article-title":"Relationship between placebo response rate and clinical trial outcome in bipolar depression","volume":"74","author":"Iovieno","year":"2016","journal-title":"J Psychiatr Res"},{"key":"R25-20240807","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.4088\/JCP.11r07485","article-title":"Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis","volume":"73","author":"Iovieno","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"R26-20240807","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","article-title":"A new definition of neuropathic pain","volume":"152","author":"Jensen","year":"2011","journal-title":"PAIN"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40200-019-00427-w","article-title":"Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial","volume":"18","author":"Joharchi","year":"2019","journal-title":"J Diabetes Metab Disord"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2337\/dc10-1793","article-title":"A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial","volume":"34","author":"Kaur","year":"2011","journal-title":"Diabetes Care"},{"key":"R29-20240807","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.NMD.0000061144.16176.38","article-title":"Placebo response and antidepressant clinical trial outcome","volume":"191","author":"Khan","year":"2003","journal-title":"J Nerv Ment Dis"},{"key":"R30-20240807","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pain.2006.10.029","article-title":"Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain","volume":"130","author":"Khoromi","year":"2007","journal-title":"PAIN"},{"key":"R31-20240807","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Ann Intern Med"},{"key":"R32-20240807","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.drudis.2016.11.022","article-title":"Are placebo and drug-specific effects additive? Questioning basic assumptions of double-blinded randomized clinical trials and presenting novel study designs","volume":"22","author":"Kube","year":"2017","journal-title":"Drug Discov Today"},{"key":"R33-20240807","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jpsychires.2007.07.003","article-title":"Is bigger better for depression trials?","volume":"42","author":"Liu","year":"2008","journal-title":"J Psychiatr Res"},{"key":"R34-20240807","doi-asserted-by":"crossref","first-page":"e84104","DOI":"10.1371\/journal.pone.0084104","article-title":"Randomised controlled trials may underestimate drug effects: balanced placebo trial design","volume":"9","author":"Lund","year":"2014","journal-title":"PLoS One"},{"key":"R35-20240807","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.2147\/DDDT.S185995","article-title":"A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy","volume":"13","author":"Majdinasab","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"R36-20240807","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJM199205073261904","article-title":"Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy","volume":"326","author":"Max","year":"1992","journal-title":"N Engl J Med"},{"key":"R37-20240807","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1049909111412539","article-title":"A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study","volume":"29","author":"Mishra","year":"2012","journal-title":"Am J Hosp Palliat Care"},{"key":"R38-20240807","first-page":"29","article-title":"Analgesic effect of duloxetine compared to nortryptiline in patients with painful neuropathy: a randomized, double-blind, placebo-controlled trial","volume":"12","author":"Mohammadali Bayani","year":"2021","journal-title":"Caspian J Intern Med"},{"key":"R39-20240807","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R40-20240807","first-page":"CD008242","article-title":"Amitriptyline for neuropathic pain in adults","volume":"2015","author":"Moore","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R41-20240807","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/archinte.159.16.1931","article-title":"Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain","volume":"159","author":"Morello","year":"1999","journal-title":"Arch Intern Med"},{"key":"R42-20240807","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.1990.tb01584.x","article-title":"A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain","volume":"82","author":"Panerai","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"R43-20240807","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"key":"R44-20240807","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/papr.12014","article-title":"A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy","volume":"13","author":"Rauck","year":"2013","journal-title":"Pain Pract"},{"key":"R45-20240807","first-page":"192","article-title":"Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial","volume":"19","author":"Razazian","year":"2014","journal-title":"Neurosciences (Riyadh)"},{"key":"R46-20240807","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"R47-20240807","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/j.pain.0000000000000454","article-title":"Pain and the global burden of disease","volume":"157","author":"Rice","year":"2016","journal-title":"PAIN"},{"key":"R48-20240807","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.apmr.2007.07.038","article-title":"Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury","volume":"88","author":"Rintala","year":"2007","journal-title":"Arch Phys Med Rehabil"},{"key":"R49-20240807","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/jamaneurol.2018.3077","article-title":"Effect of gabapentin vs pregabalin on pain intensity in adults with chronic sciatica: a randomized clinical trial","volume":"76","author":"Robertson","year":"2019","journal-title":"JAMA Neurol"},{"key":"R50-20240807","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jpain.2005.07.001","article-title":"Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial","volume":"6","author":"Rowbotham","year":"2005","journal-title":"J Pain"},{"key":"R51-20240807","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40261-019-00882-6","article-title":"Comparison of the efficacy and safety of pregabalin and duloxetine in taxane-induced sensory neuropathy: a randomized controlled trial","volume":"40","author":"Salehifar","year":"2020","journal-title":"Clin Drug Investig"},{"key":"R52-20240807","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","article-title":"The IASP classification of chronic pain for ICD-11: chronic neuropathic pain","volume":"160","author":"Scholz","year":"2019","journal-title":"PAIN"},{"key":"R53-20240807","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(05)61034-3","article-title":"Sample size calculations in randomised trials: mandatory and mystical","volume":"365","author":"Schulz","year":"2005","journal-title":"Lancet"},{"key":"R55-20240807","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/01.WNL.0000058749.49264.BD","article-title":"Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial","volume":"60","author":"Sindrup","year":"2003","journal-title":"Neurology"},{"issue":"suppl 1","key":"R56-20240807","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/j.pain.0000000000001849","article-title":"John D. Loeser Award Lecture: size does matter, but it isn't everything: the challenge of modest treatment effects in chronic pain clinical trials","volume":"161","author":"Smith","year":"2020","journal-title":"PAIN"},{"key":"R57-20240807","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(22)01472-6","article-title":"Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial","volume":"400","author":"Tesfaye","year":"2022","journal-title":"Lancet"},{"key":"R58-20240807","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.pain.2013.05.043","article-title":"Duloxetine and pregabalin: high-dose monotherapy or their combination? The \u201cCOMBO-DN study\u201d\u2014a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain","volume":"154","author":"Tesfaye","year":"2013","journal-title":"PAIN"},{"key":"R59-20240807","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.pain.2014.07.001","article-title":"Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?","volume":"155","author":"Torrance","year":"2014","journal-title":"PAIN"},{"key":"R60-20240807","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.51.4.1166","article-title":"Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial","volume":"51","author":"Watson","year":"1998","journal-title":"Neurology"},{"key":"R61-20240807","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1155\/2010\/382781","article-title":"A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain","volume":"15","author":"Watson","year":"2010","journal-title":"Pain Res Manag"},{"key":"R62-20240807","doi-asserted-by":"crossref","first-page":"e59995","DOI":"10.5812\/ircmj.59995","article-title":"Comparative efficacy of duloxetine versus nortriptyline in patients with diabetic peripheral neuropathic pain: a double blind randomized controlled trial","volume":"19","author":"Zakerkish","year":"2017","journal-title":"Iranian Red Crescent Med J"}],"container-title":["PAIN Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PR9.0000000000001138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T18:20:17Z","timestamp":1723054817000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PR9.0000000000001138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pr9.0000000000001138","relation":{},"ISSN":["2471-2531"],"issn-type":[{"value":"2471-2531","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"assertion":[{"value":"2023-10-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}